{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:03:27Z","timestamp":1789560207204,"version":"build-2803163510"},"reference-count":71,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,6,20]],"date-time":"2018-06-20T00:00:00Z","timestamp":1529452800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2018.00654","type":"journal-article","created":{"date-parts":[[2018,6,20]],"date-time":"2018-06-20T04:40:01Z","timestamp":1529469601000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":71,"title":["Pharmacotoxicology of Non-fentanyl Derived New Synthetic Opioids"],"prefix":"10.3389","volume":"9","author":[{"given":"Renata","family":"Solimini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Pichini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Pacifici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco P.","family":"Busard\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Giorgetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,6,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.1679","article-title":"On the horizon: the synthetic opioid U-49900.","volume":"9","author":"Alzghari","year":"2017","journal-title":"Cureus"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.1914","article-title":"Addressing hazards from unscheduled novel psychoactive substances as research chemicals: the case of U-50488.","volume":"9","author":"Amin","year":"2017","journal-title":"Cureus"},{"key":"B3","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.annemergmed.2016.06.014","article-title":"Fentanyl and a novel synthetic opioid U-47700 masquerading as Street \u201cNorco\u201d in Central California: a case report.","volume":"69","author":"Armenian","year":"","journal-title":"Ann. Emerg. Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.neuropharm.2017.10.016","article-title":"Fentanyl, fentanyl analogs and novel synthetic opioids: a comprehensive review.","volume":"134","author":"Armenian","year":"","journal-title":"Neuropharmacology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"609","DOI":"10.3109\/15563650.2015.1054505","article-title":"Opioid intoxications involving butyrylfentanyl, 4-fluorobutyrylfentanyl, and fentanyl from the Swedish STRIDA project.","volume":"53","author":"B\u00e4ckberg","year":"2015","journal-title":"Clin. Toxicol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.neuropharm.2017.08.016","article-title":"Pharmacological characterization of novel synthetic opioids (NSO) found in the recreational drug marketplace.","volume":"134","author":"Baumann","year":"2017","journal-title":"Neuropharmacology"},{"key":"B7","article-title":"Acute cutaneous symptom complex with subsequent cataract. The internet drug MT-45 may be the cause.","volume":"113","author":"Bradley","year":"2016","journal-title":"Lakartidningen"},{"key":"B8","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/j.1749-6632.2011.06199.x","article-title":"Designer drugs: a medicinal chemistry perspective.","volume":"1248","author":"Carroll","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1021\/jm00160a022","article-title":"Preparation and analgesic activity of (-)-11 alpha-substituted 1,2,3,4,5,6-hexahydro-6 alpha,7-(methyleneoxy)-2,6-methano-3-benzazocines.","volume":"29","author":"Cittern","year":"1986","journal-title":"J. Med. Chem."},{"key":"B10","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.forsciint.2016.05.001","article-title":"A case of acute intoxication due to combined use of fentanyl and 3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide (U-47700).","volume":"266","author":"Coopman","year":"2016","journal-title":"Forensic Sci. Int."},{"key":"B11","first-page":"75","article-title":"Spice-like herbal incense laced with the synthetic opioid U-47700.","volume":"30","author":"Coopman","year":"2017","journal-title":"Toxicol. Anal. Clin."},{"key":"B12","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/dar.12216","article-title":"AH-7921: a new synthetic opioid of abuse.","volume":"34","author":"Coppola","year":"2015","journal-title":"Drug Alcohol Rev."},{"key":"B13","doi-asserted-by":"publisher","first-page":"71","DOI":"10.17711\/SM.0185-3325.2017.010","article-title":"An approach to the new psychoactive drugs phenomenon.","volume":"40","author":"Dolengevich-Segal","year":"2017","journal-title":"Salud Ment."},{"key":"B14","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1080\/15563650.2016.1209763","article-title":"Two cases of intoxication with new synthetic opioid, U-47700.","volume":"55","author":"Domanski","year":"2017","journal-title":"Clin. Toxicol."},{"key":"B15","first-page":"79389","article-title":"Schedules of controlled substances: temporary placement of U-47700 into schedule I.","volume":"81","year":"2016","journal-title":"Final Order"},{"key":"B16","year":"2016","journal-title":"DEA Schedules Deadly Synthetic Drug U-47700. DEA News."},{"key":"B17","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/1556-4029.13517","article-title":"Report of increasing overdose deaths that include acetyl fentanyl in multiple counties of the Southwestern Region of the Commonwealth of Pennsylvania in 2015\u20132016.","volume":"63","author":"Dwyer","year":"2017","journal-title":"J. Foresic Sci."},{"key":"B18","first-page":"SE23","article-title":"Current concepts of phenylpiperidine derivatives use in the treatment of acute and chronic pain.","volume":"20","author":"Elbaridi","year":"2017","journal-title":"Pain Phys."},{"key":"B19","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1093\/jat\/bkx060","article-title":"Multiple Drug-toxicity involving novel psychoactive substances, 3-fluorophenmetrazine and U-47700.","volume":"41","author":"Ellefsen","year":"2017","journal-title":"J. Anal. Toxicol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1002\/dta.1984","article-title":"The first reported fatality associated with the synthetic opioid 3,4-dichloro-N-[2-(dimethyl amino)cyclohexyl]-N-methylbenzamide (U-47700) and implications for forensic analysis.","volume":"8","author":"Elliott","year":"2016","journal-title":"Drug Test Anal."},{"key":"B21","year":"2014","journal-title":"AH-. (7921). Report on the Risk Assessment of 34-dichloro-N-{[1-(dimethyl amino)Cyclohexyl]methyl}benzamide (AH-7921) in the Framework of the Council Decision on New Psychoactive Substances."},{"key":"B22","year":"2016","journal-title":"The Internet and Drug Markets."},{"key":"B23","year":"2017","journal-title":"High Risk Drug use and New Psychoactive Substances. EMCDDA Rapid Communication."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-06778-9","article-title":"Updating the list of known opioids through identification and characterization of the new opioid derivative 3,4-dichloro-N-(2-(diethylamino)cyclohexyl)-N-methylbenzamide (U-49900).","volume":"7","author":"Fabregat-Safont","year":"2017","journal-title":"Sci. Rep."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e30","DOI":"10.1016\/j.forsciint.2017.04.003","article-title":"Two fatalities associated with synthetic opioids: AH-7921 and MT-45.","volume":"277","author":"Fels","year":"2017","journal-title":"Forensic Sci. Int."},{"key":"B26","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1093\/jat\/bkw131","article-title":"Analysis of U-47700, a novel synthetic opioid, in human urine by LC-MS-MS and LC-QToF.","volume":"41","author":"Fleming","year":"2017","journal-title":"J. Anal. Toxicol."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/hup.2605","article-title":"Fentanyl novel derivative-related deaths.","volume":"32","author":"Giorgetti","year":"2017","journal-title":"Hum. Psychopharmacol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1093\/jat\/bkw129","article-title":"Postmortem and toxicological findings in a series of furanylfentanyl-related deaths.","volume":"41","author":"Guerrieri","year":"2017","journal-title":"J. Anal. Toxicol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jpba.2012.04.001","article-title":"Development and validation of a reliable method for studying the distribution pattern for opiates metabolites in brain.","volume":"73","author":"Guerrini","year":"2013","journal-title":"J. Pharm. Biomed. Anal."},{"key":"B30","doi-asserted-by":"publisher","first-page":"901","DOI":"10.3109\/15563650.2014.943908","article-title":"MT-45, a new psychoactive substance associated with hearing loss and unconsciousness.","volume":"52","author":"Helander","year":"2014","journal-title":"Clin. Toxicol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1080\/15563650.2017.1303141","article-title":"Intoxications involving acrylfentanyl and other novel designer fentanyls - results from the Swedish STRIDA project.","volume":"55","author":"Helander","year":"","journal-title":"Clin. Toxicol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1111\/bjd.15174","article-title":"Acute skin and hair symptoms followed by severe, delayed eye complications in subjects using the synthetic opioid MT-45.","volume":"176","author":"Helander","year":"","journal-title":"Br. J. Dermatol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.mpmed.2015.12.030","article-title":"Drugs of abuse.","volume":"44","author":"Hill","year":"2016","journal-title":"Medicine"},{"key":"B34","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1080\/15563650.2016.1209767","article-title":"A case of U-47700 overdose with laboratory confirmation and metabolite identification.","volume":"55","author":"Jones","year":"2017","journal-title":"Clin. Toxicol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/j.forsciint.2014.08.013","article-title":"Lethal poisonings with AH-7921 in combination with other substances.","volume":"244","author":"Karinen","year":"2014","journal-title":"Forensic Sci. Int."},{"key":"B36","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s11419-015-0271-z","article-title":"AH-7921: the list of new psychoactive opioids is expanded.","volume":"33","author":"Katselou","year":"2015","journal-title":"Forensic Toxicol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/B0-12-227210-2\/00260-0","article-title":"Opiates.","volume":"3","author":"Knapp","year":"2002","journal-title":"Encycl. Hum. Brain"},{"key":"B38","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1093\/jat\/bku057","article-title":"Fatal intoxications associated with the designer opioid AH-7921.","volume":"38","author":"Kronstrand","year":"2014","journal-title":"J. Anal. Toxicol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/dta.2228","article-title":"Metabolism of novel opioid agonists U-47700 and U-49900 using human liver microsomes with confirmation in authentic urine specimens from drug users.","volume":"10","author":"Krotulski","year":"2017","journal-title":"Drug Test Anal."},{"key":"B40","first-page":"1712","article-title":"MT-45\u2013a dangerous and potentially ototoxic internet drug.","volume":"111","author":"Lindeman","year":"2014","journal-title":"Lakartidningen"},{"key":"B41","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1093\/jat\/bkx031","article-title":"Reports of adverse events associated with use of novel psychoactive substances, 2013-2016: a review.","volume":"41","author":"Logan","year":"2017","journal-title":"J. Anal. Toxicol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.annemergmed.2016.08.445","article-title":"Novel synthetic opioids: an opioid epidemic within an opioid epidemic.","volume":"69","author":"Lucyk","year":"2017","journal-title":"Ann. Emerg. Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.trac.2018.01.007","article-title":"New synthetic opioids in biological and non-biological matrices: a review of current analytical methods.","volume":"102","author":"Marchei","year":"2018","journal-title":"Trends Analyt. Chem."},{"key":"B44","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1093\/jat\/bkw124","article-title":"A fatality related to the synthetic opioid U-47700: postmortem concentration distribution.","volume":"41","author":"McIntyre","year":"2017","journal-title":"J. Anal. Toxicol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1093\/jat\/bkw086","article-title":"Analysis of novel synthetic opioids U-47700, U-50488 and Furanyl fentanyl by LC-MS\/MS in postmortem casework.","volume":"40","author":"Mohr","year":"2016","journal-title":"J. Anal. Toxicol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1093\/jat\/bkx058","article-title":"Identification of MT-45 Metabolites: in silico prediction, In Vitro incubation with rat hepatocytes and In Vivo confirmation.","volume":"41","author":"Montesano","year":"2017","journal-title":"J. Anal. Toxicol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.drugpo.2015.04.003","article-title":"Fentanyls: are we missing the signs? Highly potent and on the rise in Europe.","volume":"26","author":"Mounteney","year":"2015","journal-title":"Int. J. Drug Policy"},{"key":"B48","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.biopsych.2011.08.011","article-title":"\u0394FosB enhances the rewarding effects of cocaine while reducing the pro-depressive effects of the kappa-opioid receptor agonist U50488.","volume":"71","author":"Muschamp","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1021\/jm00393a017","article-title":"Synthesis and structure-activity relationships of 1-substituted 4-(1,2-diphenylethyl)piperazine derivatives having narcotic agonist and antagonist activity.","volume":"30","author":"Natsuka","year":"1987","journal-title":"J. Med. Chem."},{"key":"B50","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1093\/jat\/bkw012","article-title":"Analysis of MT-45, a novel synthetic opioid, in human whole blood by LC-MS-MS and its identification in a drug-related death.","volume":"40","author":"Papsun","year":"2016","journal-title":"J. Anal. Toxicol."},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00785","article-title":"European drug users at risk from illicit fentanyls mix.","volume":"8","author":"Pichini","year":"","journal-title":"Front. Pharmacol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1097\/FTD.0000000000000465","article-title":"Acute intoxications and fatalities from illicit fentanyl and analogues: an update.","volume":"40","author":"Pichini","year":"","journal-title":"Ther. Drug Monit."},{"key":"B53","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1097\/ADM.0000000000000324","article-title":"Misuse of novel synthetic opioids: a deadly new trend.","volume":"11","author":"Prekupec","year":"2017","journal-title":"J. Addict Med."},{"key":"B54","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/jcpt.12640","article-title":"The fentanyl family: a distinguished medical history tainted by abuse.","volume":"43","author":"Raffa","year":"2018","journal-title":"J. Clin. Pharm. Ther."},{"key":"B55","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.jemermed.2017.05.034","article-title":"U-47700: a clinical review of the literature.","volume":"53","author":"Rambaran","year":"2017","journal-title":"J. Emerg. Med."},{"key":"B56","doi-asserted-by":"publisher","first-page":"65","DOI":"10.12788\/emed.2017.0010","article-title":"The new opioid epidemic: prescriptions, synthetics, and street drugs.","volume":"49","author":"Rao","year":"2017","journal-title":"Emerg. Med."},{"key":"B57","year":"2018","journal-title":"Legal Strong U 48800 MAF White Powder C16H22Cl2N2O For Medical Research."},{"key":"B58","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/wps.20174","article-title":"Novel psychoactive substances of interest for psychiatry.","volume":"14","author":"Schifano","year":"2015","journal-title":"World Psychiatry"},{"key":"B59","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1080\/15563650.2016.1209764","article-title":"Near death from a novel synthetic opioid labeled U-47700: emergence of a new opioid class.","volume":"55","author":"Schneir","year":"2017","journal-title":"Clin. Toxicol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/jat\/bkx049","article-title":"Confirmation of Carfentanil, U-47700 and other synthetic opioids in a human performance case by LC-MS-MS.","volume":"41","author":"Seither","year":"2017","journal-title":"J. Anal. Toxicol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1093\/jat\/bkx041","article-title":"Qualitative Identification of fentanyl analogs and other opioids in postmortem cases by UHPLC-Ion Trap-MSn.","volume":"41","author":"Shoff","year":"2017","journal-title":"J. Anal. Toxicol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.drugalcdep.2016.11.033","article-title":"A review: fentanyl and non-pharmaceutical fentanyls.","volume":"171","author":"Suzuki","year":"2017","journal-title":"Drug Alcohol Depend."},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i6848","article-title":"Novel psychoactive substances: types, mechanisms of action, and effects.","volume":"356","author":"Tracy","year":"2017","journal-title":"BMJ"},{"key":"B64","year":"","journal-title":"The Challenge of Synthetic Drugs in East and South-East Asia. Trends and Patterns of Amphetamine-type Stimulants and New Psychoactive Substances. Report from the Global SMART Programme."},{"key":"B65","year":"","journal-title":"World Drug Report 2017. Booklet 4."},{"key":"B66","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.drugpo.2016.11.007","article-title":"New psychoactive substances (NPS) on cryptomarket fora: an exploratory study of characteristics of forum activity between NPS buyers and vendors.","volume":"40","author":"Van Hout","year":"2017","journal-title":"Int. J. Drug Policy"},{"key":"B67","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1002\/dta.1856","article-title":"Metabolic characterization of AH-7921, a synthetic opioid designer drug: in vitro metabolic stability assessment and metabolite identification, evaluation of in silico prediction, and in vivo confirmation.","volume":"8","author":"Wohlfarth","year":"2016","journal-title":"Drug Test Anal."},{"key":"B68","year":"2016","journal-title":"U-47700 Critical Review Report."},{"key":"B69","year":"2017","journal-title":"WHO Expert Committee on Drug Dependence. Thirty-eight Report."},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2017.00110","article-title":"An expanding world of novel psychoactive substances: opioids.","volume":"8","author":"Zawilska","year":"2017","journal-title":"Front. Psychiatry"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugalcdep.2015.09.030","article-title":"Next generation of novel psychoactive substances on the horizon - A complex problem to face.","volume":"157","author":"Zawilska","year":"2015","journal-title":"Drug Alcohol Depend."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2018.00654\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,6,20]],"date-time":"2018-06-20T04:40:06Z","timestamp":1529469606000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2018.00654\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,20]]},"references-count":71,"alternative-id":["10.3389\/fphar.2018.00654"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2018.00654","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,20]]},"article-number":"654"}}